These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 29904838

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. OnabotulinumtoxinA for chronic migraine.
    Blumenfeld A, Evans RW.
    Headache; 2012 Jan; 52(1):142-8. PubMed ID: 22268776
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. What is changing in chronic migraine treatment? An algorithm for onabotulinumtoxinA treatment by the Italian chronic migraine group.
    Sacco S, Russo A, Geppetti P, Grazzi L, Negro A, Tassorelli C, Tedeschi G, Martelletti P.
    Expert Rev Neurother; 2020 Dec; 20(12):1275-1286. PubMed ID: 32990477
    [Abstract] [Full Text] [Related]

  • 6. OnabotulinumtoxinA for treatment of chronic migraine: a response.
    Dodick DW, Turkel CC, Degryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF.
    Headache; 2011 Jun; 51(6):1005-8. PubMed ID: 21592099
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Botulinum neurotoxin A for chronic migraine headaches: does it work and how?
    Cairns BE, Gazerani P.
    Pain Manag; 2014 Jun; 4(6):377-80. PubMed ID: 25494688
    [No Abstract] [Full Text] [Related]

  • 10. Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study.
    Young WB, Ivan Lopez J, Rothrock JF, Orejudos A, Manack Adams A, Lipton RB, Blumenfeld AM.
    J Headache Pain; 2019 Feb 01; 20(1):12. PubMed ID: 30709333
    [Abstract] [Full Text] [Related]

  • 11. OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine.
    Lipton RB, Varon SF, Grosberg B, McAllister PJ, Freitag F, Aurora SK, Dodick DW, Silberstein SD, Diener HC, DeGryse RE, Nolan ME, Turkel CC.
    Neurology; 2011 Oct 11; 77(15):1465-72. PubMed ID: 21956721
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Botulinum toxin A and migraine surgery.
    Guyuron B, Tucker T, Kriegler J.
    Plast Reconstr Surg; 2003 Oct 11; 112(5 Suppl):171S-173S; discussion 174S-176S. PubMed ID: 14504501
    [No Abstract] [Full Text] [Related]

  • 17. IncobotulinumtoxinA for Migraine: A Retrospective Case Series.
    Kazerooni R, Lim J, Ashley Blake P, Lessig S.
    Clin Ther; 2015 Aug 11; 37(8):1860-4. PubMed ID: 26166734
    [Abstract] [Full Text] [Related]

  • 18. Wearing Off Response to OnabotulinumtoxinA in Chronic Migraine: Analysis in a Series of 193 Patients.
    Quintas S, García-Azorín D, Heredia P, Talavera B, Gago-Veiga AB, Guerrero ÁL.
    Pain Med; 2019 Sep 01; 20(9):1815-1821. PubMed ID: 30657951
    [Abstract] [Full Text] [Related]

  • 19. CALCA and TRPV1 genes polymorphisms are related to a good outcome in female chronic migraine patients treated with OnabotulinumtoxinA.
    Moreno-Mayordomo R, Ruiz M, Pascual J, Gallego de la Sacristana M, Vidriales I, Sobrado M, Cernuda-Morollon E, Gago-Veiga AB, Garcia-Azorin D, Telleria JJ, Guerrero AL.
    J Headache Pain; 2019 Apr 23; 20(1):39. PubMed ID: 31014225
    [Abstract] [Full Text] [Related]

  • 20. Effect of OnabotulinumtoxinA Injection on Depression in Chronic Migraine.
    Maasumi K, Thompson NR, Kriegler JS, Tepper SJ.
    Headache; 2015 Oct 23; 55(9):1218-24. PubMed ID: 26381856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.